grant

Polyalanine Tails: A Novel Type of Protein Modification Implicated in Neurodegeneration

Organization JACKSON LABORATORYLocation BAR HARBOR, UNITED STATESPosted 1 Aug 2017Deadline 31 May 2027
NIHUS FederalResearch GrantFY20251-Ethyl-1-nitrosoureaAddressAlanineAmyotrophic Lateral SclerosisAmyotrophic Lateral Sclerosis Motor Neuron DiseaseAssayBacteriaBasic ResearchBasic ScienceBehavioralBindingBioassayBiochemicalBiological AssayBiologyBody TissuesC-terminalCausalityCell BodyCell modelCellsCellular modelComplexDNA mutationDataDefectDegenerative Neurologic DisordersDevelopmentDiseaseDisorderDysfunctionE3 LigaseE3 Ubiquitin LigaseENUEthylnitrosoureaEtiologyExhibitsFunctional disorderFundingGehrig's DiseaseGenesGenetic ChangeGenetic defectGenetic mutationGoalsHereditaryHistopathologyHumanInduced DNA AlterationInduced MutationInduced Sequence AlterationInheritedInterventionInvestigationKnowledgeLeadLightLou Gehrig DiseaseLytotoxicityMammalian CellMediatingMedulla SpinalisMiceMice MammalsModelingModern ManModificationMolecularMolecular InteractionMotorMotor CellMotor Neuron DiseaseMotor NeuronsMouse StrainsMurineMusMutationN-Ethyl-N-nitrosoureaN-ethyl-N-nitroso-ureaNerve CellsNerve DegenerationNerve UnitNervous System Degenerative DiseasesNervous System DiseasesNervous System DisorderNeural CellNeural Degenerative DiseasesNeural degenerative DisordersNeurocyteNeurodegenerative DiseasesNeurodegenerative DisordersNeurologic Degenerative ConditionsNeurologic DisordersNeurological DisordersNeuromuscular DiseasesNeuromuscular conditionsNeuron DegenerationNeuronsNitrosoethylureaNitrosourea CompoundsNuclear ExportOrthologOrthologous GenePalsyParalysedPatientsPb elementPhenocopyPhenotypePhotoradiationPhysiopathologyPlayPlegiaPost-Translational Modification Protein/Amino Acid BiochemistryPost-Translational ModificationsPost-Translational Protein ModificationPost-Translational Protein ProcessingPosttranslational ModificationsPosttranslational Protein ProcessingPrevalenceProtein CleavageProtein ModificationProteinsProteolysisPublic HealthQuality ControlReportingResearchResearch ProposalsRibosomesRoleSocietiesSpinal CordSystemTailTestingTissuesToxic effectToxicitiesTranslationsUbiquitin Protein LigaseUbiquitin-Protein Ligase ComplexesUbiquitin-Protein Ligase E3VariantVariationWorkYeastsaged groupaged groupsaged individualaged individualsaged peopleaged personaged personsaged populationaged populationsaging populationbasebasescausal allelecausal genecausal mutationcausal variantcausationcausative mutationcausative variantcofactorcytotoxicitydegenerative diseases of motor and sensory neuronsdegenerative disorder of motor neuronsdegenerative neurological diseasesdesigndesigningdevelopmentaldisease causationearly onsetfitnessgenome mutationheavy metal Pbheavy metal leadhuman diseaseinsightinsoluble aggregateloss of functionmotoneuronmouse modelmurine modelmutantmyoneural disorderneural degenerationneurodegenerationneurodegenerativeneurodegenerative illnessneurodegenerative phenotypeneurological degenerationneurological diseaseneuromuscular degenerative disorderneuromuscular disorderneuronalneuronal degenerationneuroprotectionneuroprotectivenew drug treatmentsnew drugsnew pharmacological therapeuticnew therapeuticsnew therapynext generation therapeuticsnitrosoureanovelnovel drug treatmentsnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel therapeuticsnovel therapyparalysisparalyticpathophysiologypolyalaninepolypeptidepopulation agingprotein aggregateprotein aggregationsALSsocial rolesporadic ALSsporadic amyotrophic lateral sclerosistherapeutically effectivetranslationubiquitin-protein ligase
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Among the costliest diseases to society, and with rising prevalence in an aging population, neurodegenerative
diseases pose a public health challenge. However, there are few options available for their treatment, and

without pathomechanisms being sufficiently elucidated, one's ability to generate a rationale for interventions is

greatly limited. Our studies are expected to address this barrier by establishing new etiological factors and

molecular mechanisms of mammalian neurodegeneration. One such mechanism is Ribosome-associated

Quality Control (RQC), that mediates the degradation of incomplete polypeptides produced by ribosomes that

stall during translation. Key factors working in RQC are the Ltn1/Listerin E3 ubiquitin ligase and its partner,

NEMF (Rqc2 in yeast). PI Joazeiro has previously found that Ltn1 mutation causes neurodegeneration in mice.

PI Cox has more recently identified two independent mutations in mouse Nemf causing motor neuron disease

and used this to knowledge to identify previously undiagnosed patients with a similar neuromuscular condition

that inherited causative mutations in the human NEMF gene. In several ways, Ltn1-ENU and Nemf-ENU mice

phenocopy each other, thus strengthening the connection between RQC dysfunction and neurodegeneration.

The proposed studies are aimed at understanding molecular mechanisms underlying neurodegeneration

caused by NEMF loss of function. We focus our analyses on a recently-discovered activity of NEMF that is

conserved from bacteria to humans–the modification of aberrant nascent chains with C-terminal Alanine tails

that have a proteolytic function. Based on our preliminary data, we hypothesize that NEMF-mediated Ala tailing

protects neurons against degeneration. Results of these studies are expected to provide critical understanding

of how defects in protein quality control lead to neurological disease.

Grant Number: 5R01NS102414-09
NIH Institute/Center: NIH

Principal Investigator: Robert Burgess

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →